Shilpa Medicare Ltd
₹336
(-0.78%)
Thu, 12 Mar 2026, 04:06 pm
Health Technology
Pharmaceuticals: Major
24.5KShilpa Medicare Share Price Live Chart
1 Day
0 (0%)
No Result Found
Summary
Market Cap
6629.25
Net Profit
78.30
P/B
2.73
Sector P/E
32.36
P/E
82.77
EV/EBITDA
22.66
Debt/Equity (Industry)
0.26
Interest Cover (Industry)
10.89
ROCE (Industry)
16.43
RONW (Industry)
14.36
ROE
4.21
ROCE
7.69
Debt/Equity
0.36
EPS (TTM)
9.05
Dividend Yield
0.15
Book Value
124.61
Interest Cover
2.94
Analysis
all
- Cash flow for Shilpa Medicare is expected to increase by more than 50% in 2 years time.
- Shilpa Medicare's earnings growth is expected to exceed the low risk savings rate of 7.2%.
- Shilpa Medicare's earnings are expected to exceed the low risk growth rate next year.
- Shilpa Medicare is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
- Shilpa Medicare is profitable, therefore cash runway is not a concern.
- Shilpa Medicare is not paying a notable dividend for India, therefore no need to check if the payments are increasing.
- No need to calculate the sustainability of Shilpa Medicare's dividends as it is not paying a notable one for India.
- No need to calculate the sustainability of Shilpa Medicare's dividends in 3 years as they are not expected to pay a notable one for India.
- Shilpa Medicare is not paying a notable dividend for India, therefore no need to check if the payments are stable.
- Shilpa Medicare's pays a lower dividend yield than the bottom 25% of dividend payers in India (0.76%).
Shareholding
| Shareholders | DEC 2025 | SEPT 2025 | JUN 2025 | MAR 2025 | DEC 2024 |
|---|---|---|---|---|---|
| Promoters | 40.13 | 44.23 | 44.23 | 44.23 | 44.23 |
| FII | 10.97 | 10.92 | 11.19 | 10.97 | 9.90 |
| DII | 8.33 | 7.67 | 7.46 | 7.55 | 8.27 |
| Public | 40.57 | 37.19 | 37.12 | 37.25 | 37.60 |
| Government | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Technical Analysis
Support and Resistance
| Type | R3 | R2 | R1 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | 477.65 | 398.75 | 367.70 | 319.85 | 288.80 | 240.95 | 162.05 |
| Fibonacci | 398.75 | 368.61 | 349.99 | 319.85 | 289.71 | 271.09 | 240.95 |
| Camarilla | 358.35 | 351.11 | 343.88 | 319.85 | 329.42 | 322.19 | 314.95 |
Pivots Level: Classic
R3
+157.80
477.65
R2
+78.90
398.75
R1
+47.85
367.70
S1
-31.05
288.80
S2
-78.90
240.95
S3
-157.80
162.05
Moving Average
Period
Value
10-EMA
331.30
20-EMA
327.18
30-EMA
323.94
50-EMA
323.02
100-EMA
334.21
200-EMA
350.97
Corporate Actions
| Announcement Date | Purpose | Action | Ex Date |
|---|---|---|---|
| 06 Feb 2026 | board-meetings | Quarterly Results | |
| 13 Nov 2025 | board-meetings | Quarterly Results | |
| 18 Sept 2025 | bonus | 1:1 Bonus Issue of Equity Shares | 03 Oct 2025 |
| 03 Sept 2025 | bonus | Bonus issue 1:1 | 03 Oct 2025 |
| 17 Aug 2025 | dividend | Final Dividend - Rs. - 1 | 17 Sept 2025 |
| 13 Aug 2025 | agm | ||
| 26 May 2025 | dividend | ₹1.00 Dividend /Share | 17 Sept 2025 |
| 08 Aug 2024 | agm | ||
| 06 Aug 2024 | agm | Annual General Meeting | 09 Sept 2024 |
| 01 Sept 2023 | agm |
Peer Comparison
Shilpa Medicare Ltd
Torrent Pharmaceuticals Ltd
Sun Pharmaceutical Industries Ltd
Divis Laboratories Ltd
Cipla Ltd
Dr Reddys Laboratories Ltd
Shilpa Medicare Ltd About
Shilpa Medicare engaged in the manufacturing of API, Formulation and Development service.
Industry
Pharmaceuticals - Indian - Formulations
Founded
1987
Headquarters
CEO
Omprakash Inani
Employees
Contact
Website
http://www.vbshilpa.com
info@vbshilpa.com
Phone
91-8532-238704
Location
#12-6-214/A1, Hyderabad Road, Raichur, Karnataka, 584135
Shilpa Medicare Ltd Company History
| Year | History |
|---|---|
| 2020 |
|
| 2021 |
|
| 2022 |
|
| 2023 |
|
| 2024 |
|
Deals
| Client Name | Order Side | QTY | Avg Price | Date |
|---|---|---|---|---|
| THE VANGUARD GROUP INC AC VANGUARD TOTAL INTERNATIONAL STOCK INDEX FUND | Buy | 547853 | 683.03 | 21 Mar 2025 |
| PLUTUS WEALTH MANAGEMENT LLP | Buy | 750000 | 492.34 | 05 Jun 2024 |
| GRAVITON RESEARCH CAPITAL LLP | Buy | 482523 | 443.95 | 21 Feb 2024 |
| GRAVITON RESEARCH CAPITAL LLP | Sell | 482523 | 444.09 | 21 Feb 2024 |
| TA FII INVESTORS LIMITED | Sell | 500000 | 422.22 | 20 Feb 2024 |
| TA FII INVESTORS LIMITED | Sell | 1345000 | 407.05 | 19 Feb 2024 |
| GRAVITON RESEARCH CAPITAL LLP | Buy | 578067 | 404.63 | 19 Feb 2024 |
| GRAVITON RESEARCH CAPITAL LLP | Sell | 578067 | 404.48 | 19 Feb 2024 |
| GRAVITON RESEARCH CAPITAL LLP | Buy | 771081 | 272.92 | 30 Jun 2023 |
| GRAVITON RESEARCH CAPITAL LLP | Sell | 771081 | 273.06 | 30 Jun 2023 |
Open Your Free Demat Account Now!
Facebook
Twitter
Instagram
LinkedIn
Youtube
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800